Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
Authors:
- Allison E. KennedyAKAllison E. Kennedy
- Laura CookLaura Cook
- Jessica A. BreznikJBJessica A. Breznik
- Braeden CowbroughBCBraeden Cowbrough
- Jessica G. WallaceJWJessica G. Wallace
- Angela HuynhAHAngela Huynh
- James W. SmithJSJames W. Smith
- Kiho SonKSKiho Son
- Hannah StaceyHSHannah Stacey
- Jann AngJAJann Ang
- Allison McGeerAMAllison McGeer
- Brenda L. ColemanBCBrenda L. Coleman
Open Access
Abstract
Survivors of severe SARS-CoV-2 infections frequently suffer from a range of post-infection sequelae. Whether survivors of mild or asymptomatic infections can expect any long-term health consequences is not yet known. Herein we investigated lasting changes to soluble inflammatory factors and cellular immune phenotype and function in individuals who had recovered from mild SARS-CoV-2 infections (n = 22), compared to those that had recovered from other mild respiratory infections (n = 11). Individuals who had experienced mild SARS-CoV-2 infections had elevated levels of C-reactive protein 1–3 months after symptom onset, and changes in phenotype and function of circulating T-cells that were not apparent in individuals 6–9 months post-symptom onset. Markers of monocyte activation, and expression of adherence and chemokine receptors indicative of altered migratory capacity, were also higher at 1–3 months post-infection in individuals who had mild SARS-CoV-2, but these were no longer elevated by 6–9 months post-infection. Perhaps most surprisingly, significantly more T-cells could be activated by polyclonal stimulation in individuals who had recently experienced a mild SARS-CoV-2, infection compared to individuals with other recent respiratory infections. These data are indicative of prolonged immune activation and systemic inflammation that persists for at least three months after mild or asymptomatic SARS-CoV-2 infections.Keywords
All Related Versions
Funding Information
- Canadian Institutes of Health Research (FDN-154304)
- Ontario Research Fund (ORF) COVID-19 Rapid Research Fund (#C-191-2426729-NAZY)
- W. Garfield Weston Family Foundation (NA)
This publication has 43 references indexed in Scilit:
- Human antigen‐specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responsesEuropean Journal of Immunology, 2014
- Establishment of a healthy human range for the whole blood ‘OX40’ assay for the detection of antigen-specific CD4+ T cells by flow cytometryCytometry Part B: Clinical Cytometry, 2014
- The Development and Function of Memory Regulatory T Cells after Acute Viral InfectionsThe Journal of Immunology, 2012
- Influenza A Virus Infection Results in a Robust, Antigen-Responsive, and Widely Disseminated Foxp3 + Regulatory T Cell ResponseJournal of Virology, 2012
- Tregs control the development of symptomatic West Nile virus infection in humans and miceJournal of Clinical Investigation, 2009
- High Levels of Human Antigen-Specific CD4+ T Cells in Peripheral Blood Revealed by Stimulated Coexpression of CD25 and CD134 (OX40)The Journal of Immunology, 2009
- Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling BehaviorScience, 2007
- Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificitiesBlood, 2007
- Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like diseaseNature Medicine, 2007
- Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface.Journal of Clinical Investigation, 1987